Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label pilot study of fluoxetine in typical Rett syndrome
2008-000787-16Phase 2Terminated
- Sponsor
- Inserm
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fluoxetine in Rett syndrome (RTT), sponsored by Inserm. Primary endpoint: Global Percy score percent change at 3 months. Started Apr 2008; status: terminated.
02
Drugs
fluoxetine
03
Conditions
Rett syndrome (RTT)
Beyond the preview
Go deeper on 2008-000787-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000787-16.